Form 4: Axon Enterprise Director Julie A. Cullivan Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Director Julie A. Cullivan sold 657 shares of Axon Enterprise, Inc. common stock at $700 per share on May 12, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- On May 12, 2025, Julie A. Cullivan, a director of Axon Enterprise, Inc., sold 657 shares of common stock.
- The transaction was executed at a price of $700 per share.
- Following the transaction, Cullivan directly owns 1,735 shares of Axon Enterprise, Inc.
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on June 6, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine transaction under a pre-arranged trading plan. There is no indication of positive or negative implications for the company.
Industry Context
Sales by insiders are a normal part of corporate governance. The use of a 10b5-1 trading plan suggests the insider is selling shares in a pre-planned manner to avoid accusations of trading on inside information.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder sentiment, but the existence of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 2024-06-06 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| 2025-05-12 | Date of the transaction (sale of shares) |
| 2025-05-13 | Date of signature |
Keywords
Axon Enterprise, Director, Share Sale, Julie A. Cullivan, Form 4, 10b5-1 Trading Plan, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.